310 related articles for article (PubMed ID: 35729453)
1. Role of RAGE in the Pathogenesis of Neurological Disorders.
Juranek J; Mukherjee K; Kordas B; Załęcki M; Korytko A; Zglejc-Waszak K; Szuszkiewicz J; Banach M
Neurosci Bull; 2022 Oct; 38(10):1248-1262. PubMed ID: 35729453
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors.
Singh H; Agrawal DK
Drug Dev Res; 2022 Sep; 83(6):1257-1269. PubMed ID: 35781678
[TBL] [Abstract][Full Text] [Related]
3. Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases.
Yue Q; Song Y; Liu Z; Zhang L; Yang L; Li J
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956875
[TBL] [Abstract][Full Text] [Related]
4. Astrocyte´s RAGE: More Than Just a Question of Mood.
Gonzalez-Reyes RE; Rubiano MG
Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):39-48. PubMed ID: 27149992
[TBL] [Abstract][Full Text] [Related]
5. Glycation & the RAGE axis: targeting signal transduction through DIAPH1.
Shekhtman A; Ramasamy R; Schmidt AM
Expert Rev Proteomics; 2017 Feb; 14(2):147-156. PubMed ID: 27967251
[TBL] [Abstract][Full Text] [Related]
6. The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications.
Ramasamy R; Shekhtman A; Schmidt AM
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562970
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of RAGE Axis Signaling: A Pharmacological Challenge.
Rojas A; Morales M; Gonzalez I; Araya P
Curr Drug Targets; 2019; 20(3):340-346. PubMed ID: 30124149
[TBL] [Abstract][Full Text] [Related]
8. Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration.
Kinscherf NA; Pehar M
Curr Drug Targets; 2022; 23(12):1191-1209. PubMed ID: 35702767
[TBL] [Abstract][Full Text] [Related]
9. RAGE and its ligands: from pathogenesis to therapeutics.
Jangde N; Ray R; Rai V
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):555-575. PubMed ID: 32933340
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of RAGE in inflammatory diseases.
Dong H; Zhang Y; Huang Y; Deng H
Front Immunol; 2022; 13():931473. PubMed ID: 35967420
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function.
Braley A; Kwak T; Jules J; Harja E; Landgraf R; Hudson BI
J Biol Chem; 2016 Jun; 291(23):12057-73. PubMed ID: 27022018
[TBL] [Abstract][Full Text] [Related]
12. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
[TBL] [Abstract][Full Text] [Related]
13. Signal Diversity of Receptor for Advanced Glycation End Products.
Sakaguchi M; Kinoshita R; Putranto EW; Ruma IMW; Sumardika IW; Youyi C; Tomonobu N; Yamamoto KI; Murata H
Acta Med Okayama; 2017 Dec; 71(6):459-465. PubMed ID: 29276218
[TBL] [Abstract][Full Text] [Related]
14. Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes.
Le Bagge S; Fotheringham AK; Leung SS; Forbes JM
Med Res Rev; 2020 Jul; 40(4):1200-1219. PubMed ID: 32112452
[TBL] [Abstract][Full Text] [Related]
15. The RAGE signaling in osteoporosis.
Zhou J; Liu S; Bi S; Kong W; Qian R; Xie X; Zeng M; Jiang X; Liao Z; Shuai M; Liu W; Cheng L; Wu M
Biomed Pharmacother; 2023 Sep; 165():115044. PubMed ID: 37354815
[TBL] [Abstract][Full Text] [Related]
16. Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.
Leerach N; Harashima A; Munesue S; Kimura K; Oshima Y; Goto H; Yamamoto H; Higashida H; Yamamoto Y
Glycoconj J; 2021 Jun; 38(3):303-310. PubMed ID: 33108607
[TBL] [Abstract][Full Text] [Related]
17. 22016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis and Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage.
Schmidt AM
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):613-621. PubMed ID: 28183700
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
[TBL] [Abstract][Full Text] [Related]
19. An Aptamer-Based Antagonist against the Receptor for Advanced Glycation End-Products (RAGE) Blocks Development of Colorectal Cancer.
Zheng J; Zhu W; He F; Li Z; Cai N; Wang HH
Mediators Inflamm; 2021; 2021():9958051. PubMed ID: 34035661
[TBL] [Abstract][Full Text] [Related]
20. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
